Travere Therapeutics Inc. (TVTX)
Market Open
1 Sep, 18:40
NASDAQ (NMS) NASDAQ (NMS) Primary $
65. 89
-0.39
-0.5813%
$
6.16B Market Cap
- P/E Ratio
- Div Yield
500,323 Volume
-3.18 Eps
$ 66.28
Previous Close 
Want to track TVTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Travere Therapeutics Inc. (TVTX) Statistics
Valuation metrics
Market Cap 6.16B
Enterprise value 6.61B
Trailing P/E (ttm) -145.93
Forward P/E -
PEG ratio 1.28
Price/Sales (ttm) 10.33
Price/Book (mrq) 250.34
Enterprise Value/Revenue 11.17
Enterprise Value/EBITDA 4,278.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.17M
Average volume (90 days) 1.5M
Price summary
52-Week low 17.27
52-Week high 67.85
Beta -
50-Day moving average 58.64
200-Day moving average 38.08
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 2 Nov 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.07%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.23
Total debt (mrq) -
Total Debt/Equity (mrq) 25.16
Current ratio (mrq) 4.05%
Book value per share (mrq) 0.26
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
